R&D Changing Faces: Pharma and biotech hires, August 2026 August brought another wave of leadership changes across biotech, pharma, and research organisations.
R&D Trial complexity is the new normal When operationalised effectively, RBQM can support earlier risk detection and more targeted quality improvement.
R&D Mosquitoes, malaria, and UK R&D viral disease vaccine invest... The UK must sustain investment in malaria R&D as it faces a “perfect storm” of challenges, including mosquito resistance to existing tools.
R&D Scientists and algorithms: Finding the right balance in mode... The future of drug development is not scientists versus algorithms. It is scientists and algorithms working together.
R&D Back to basics: X-ray inspection in pharmaceutical and medic... In pharma manufacturing, x-ray inspection supports a range of quality control processes.
R&D Decarbonising respiratory care requires a new kind of generi... Generics manufacturers have long played a critical role in supporting the sustainability of the NHS, delivering affordable medicines at scale, expanding patient access, and helping healthca
Oncology ESMO26: Lowering toxicity, extending lives, with Syncromune As the ESMO26 Congress commences in Madrid, pharmaphorum invited Syncromune Executive Chairman Dr Chuck Link onto the podcast.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
